INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 458m ago
HOUSE PTR58m ago
SEC 13F58m ago
ROBINHOOD CHAIN58m ago
BJ
Corporate insider

Brille Brian J

Director, See RemarksCIK 0002071959

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 1
Max Insider Score55
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Option exercise
M$976K
400.0K sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Caris Life Sciences, Inc.Director, See Remarks · Dec 12, 2025
17
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Option exercise
M
—
400.0K sh
Sep 17, 2026
Sep 17, 2026
traded Sep 17, 2026
+0d
SEC FORM 4

Evidence

55
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Open-market sale
SELL$12.13M
400.0K sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC FORM 4

Evidence

16
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Tax withholding
F$213K
14.0K sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC FORM 4

Evidence

21
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Grant or award
A—
83.2K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

12
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Gift
G—
650 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC FORM 4

Evidence

12
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Gift
G—
650 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence